AcquireROI Funds Expansion With Investment From Decathlon Capital Partners
Growth of the software company will be supported through a company-friendly, growth debt package
AcquireROI helps organizations optimize recruitment strategies through innovative technology and a results-focused approach. The company's suite of solutions—including Acquire 360, Acquire Apply, and Acquire Advertising Agent—empowers employers and agencies to attract, engage, and hire top talent more efficiently.
No equity, ownership, or control of AcquireROI was exchanged for the capital from Decathlon Capital Partners. AcquireROI will repay the investment through future revenues.
About AcquireROI
AcquireROI delivers performance-driven talent acquisition and recruitment marketing solutions to employers, ad agencies, and candidates. Through its innovative technology and data-backed strategies, Acquire helps organizations optimize recruiting processes, maximize ROI, and achieve hiring goals efficiently. AcquireROI partners with companies across the
About Decathlon Capital Partners
Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized private debt financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding. With offices in
View original content:https://www.prnewswire.com/news-releases/acquireroi-funds-expansion-with-investment-from-decathlon-capital-partners-302447612.html
SOURCE AcquireROI
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Matt Maglodi Racing Announces New Small Business Motorsports Sponsorship Program Combining Grassroots Racing With Digital Marketing
- Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections
- Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share